CONVERSION THERAPY

Clinical trials for CONVERSION THERAPY explained in plain language.

Never miss a new study

Get alerted when new CONVERSION THERAPY trials appear

Sign up with your email to follow new studies for CONVERSION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New drug cocktail aims to shrink liver tumors for surgery

Disease control Recruiting now

This study tests a combination of four drugs (ipilimumab, sintilimab, bevacizumab biosimilar, and chemotherapy into the liver artery) in 43 adults with advanced liver cancer that cannot be removed by surgery. The goal is to shrink the tumors enough so that surgery becomes possibl…

Matched conditions: CONVERSION THERAPY

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

CONVERSION THERAPY

Get alerted when new CONVERSION THERAPY trials appear

New drug cocktail aims to shrink liver tumors for surgery